Last week, Healio provided live coverage of Digestive Disease Week, which was held in person for the first time in 2 years. One presentation at the conference focused on an association between dog ownership and Crohn’s disease. Researchers reported that ownership and close interactions with dogs in early childhood appeared to protect against the development of Crohn’s disease later in life. It was the top story in gastroenterology last week.
Author: Praveen Suthrum
The American Society for Gastrointestinal Endoscopy recently released new clinical guidance on the screening for pancreatic cancer in people with genetic susceptibility (Gastrointest Endosc 2022 Feb 16. doi:10.1016/j.gie.2021.12.001). GEN’s Sarah Tilyou spoke with lead author Mandeep S. Sawhney, MD, MS, FASGE, a gastroenterologist at Beth Israel Deaconess Medical Center and an associate professor of medicine at Harvard Medical School, in Boston, about the impetus for the guidelines and what they mean to GI practice.
This is episode 4 of 6 from our program: Obesity in GI Care: Start the Conversation, Change the Narrative. Over the course of 6 podcast episodes and 3 webinars, you’ll learn a comprehensive approach to diagnosing and treating obesity, with a specific focus on patients with GI comorbidities. This series highlights key findings and strategies from AGA’s 2017 Practice guide on Obesity and Weight management, Education and Resources (POWER program).
Over the past 3 decades, eosinophilic esophagitis (EoE) transformed from a little-known condition to a well-characterized disease often encountered in clinical practice. The Index of Severity for EoE (I-SEE) is now available for you to use as a tool to help assess EoE patients. Developed by a multidisciplinary team of experts, the new tool is now published in Gastroenterology.
In the last 12 months, there has been a plethora of factors that have inched up the consumer price index, the key gauge the Federal Reserve uses as a barometer of inflation. In a 2021 column, we defined inflation as the general increase in cost of products and services, as well as a decline in the purchasing value of money. A simple way to understand the root causes of this phenomenon is that too many dollars end up chasing too few goods.
Nearly two-thirds of patients with Crohn’s perianal fistulas treated with the novel stem cell–based drug darvadstrocel achieved clinical remission and had significantly improved quality of life, according to new six-month data presented at the 2022 meeting of the European Crohn’s and Colitis Organisation. Of the patients who received darvadstrocel (Takeda), which is not yet approved for use in the United States, 65% showed clinical remission at six months in both treatment cohorts, and 73% and 74% showed a clinical response.
We’re honored to announce that John M. Carethers, MD, AGAF, affectionately nicknamed ‘The Rock,’ will begin his term as the 117th president of the AGA Institute on June 1, 2022. He currently serves as John G. Searle professor of internal medicine and chair of the department of internal medicine at the University of Michigan Health System, a position he has held since 2009.
In the future, biopsies may not always be needed to diagnose nonalcoholic steatohepatitis, according to a new analysis of real-world data. Instead, noninvasive tests may one day offer a less expensive and less burdensome option. The analysis, from the TARGET-NASH cohort, found that past pathology reports used to identify signs of NASH often are missing documentation of critical diagnostic features, and no matter what information is included, pathologists often disagreed about the severity of various histologic findings indicative of NASH.
We don’t have jetpacks, flying cars, or teleportation pods, as futurists of the ‘60s imagined we would, but artificial intelligence-assisted shit-scanning apps are amongst the many pleasures of the 21st century. One app, Dieta Mobile, uses AI to describe poop more accurately than patients themselves, according to a new randomized clinical trial presented at the Digestive Disease Week conference in San Diego over the weekend.
PITTSBURGH, June 1, 2022 /PRNewswire/ — Saneso Inc., a leading US developer of next gen endoscope systems announces today the US Food and Drug Administration (FDA) has granted 510(k) clearance of its novel integrated 360° field of view colonoscope.